NCT03500757View on ClinicalTrials.gov

Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

April 29, 2018

Primary Completion Date

August 17, 2020

Study Completion Date

May 16, 2022

Conditions
Percutaneous Tumor Ablation
Interventions
DEVICE

HoloLens

use the HoloLens to evaluate new 3D holographic guidance and navigation for percutaneous ablation of solid tumors

Trial Locations (1)

44195

Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
lead

Case Comprehensive Cancer Center

OTHER

NCT03500757 - Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation | Biotech Hunter | Biotech Hunter